Does Adjunctive Naturopathic Care Decrease Survival Rates in Breast Cancer Patients?

Código QR

Does Adjunctive Naturopathic Care Decrease Survival Rates in Breast Cancer Patients?

Guardado en:

Detalles Bibliográficos
Autor principal:	Keith I. Block MD
Formato:	article
Lenguaje:	EN
Publicado:	SAGE Publishing 2021
Materias:	Neoplasms. Tumors. Oncology. Including cancer and carcinogens RC254-282
Acceso en línea:	https://doaj.org/article/5ec45acce21541a3bbe8337c1bd9a002
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Disease Free Survival in Breast Cancer Patients Who Receive Naturopathic Oncology Care
por: Leanna J. Standish ND, PhD, MSAOM, LAcup, FABNO
Publicado: (2021)

Decreased risk of breast cancer associated with oral bisphosphonate therapy
por: Mathew A, et al.
Publicado: (2012)

Tissue-agnostic drug approvals: how does this apply to patients with breast cancer?
por: Luiza N. Weis, et al.
Publicado: (2021)

Does Veritas&reg; play a role in breast reconstruction? a case report
por: De Vita F, et al.
Publicado: (2011)

Patients opting for breast reconstruction following mastectomy: an analysis of uptake rates and benefit
por: Howard-McNatt MM
Publicado: (2013)

A careful reassessment of anthracycline use in curable breast cancer
por: Sara Alsterlind Hurvitz, et al.
Publicado: (2021)

The Clinicopathological Features and Overall Survival of Patients With Gastric Neuroendocrine Carcinoma
por: Bin Xu MD, et al.
Publicado: (2021)

Association between the histopathological growth patterns of liver metastases and survival after hepatic surgery in breast cancer patients
por: Ali Bohlok, et al.
Publicado: (2020)

A randomized intervention involving family to improve communication in breast cancer care
por: Jennifer L. Wolff, et al.
Publicado: (2021)

Optimal delivery of male breast cancer follow-up care: improving outcomes
por: Ferzoco RM, et al.
Publicado: (2015)

Acral Lentiginous Melanoma: A United States Multi-Center Substage Survival Analysis
por: Avani M. Kolla BPhil, et al.
Publicado: (2021)

p130Cas substrate domain signaling promotes migration, invasion, and survival of estrogen receptor-negative breast cancer cells
por: Anna C Cunningham-Edmondson, et al.
Publicado: (2009)

Evaluation of overall survival and barriers to surgery for patients with breast cancer treated without surgery: a National Cancer Database analysis
por: D. Boyce-Fappiano, et al.
Publicado: (2021)

Impact of dose-dense neoadjuvant chemotherapy on pathologic response and survival for HER2-positive breast cancer patients who receive trastuzumab
por: Lize Wang, et al.
Publicado: (2021)

Pathological response rate in hormone-positive breast cancer patients treated with neoadjuvant FEC and triweekly docetaxel: a case series
por: Kiba T, et al.
Publicado: (2015)

Post-transplantation Fluorine-18 Fluorodeoxyglucose Positron Emission Tomography in Patients with Lymphoblastic Lymphoma is an Independent Prognostic Factor with an Impact on Progression-Free Survival but not Overall Survival
por: Na Dai MD, et al.
Publicado: (2021)

Comparative study analyzing survival and safety of bevacizumab/carboplatin/paclitaxel versus carboplatin/docetaxel in initial treatment of metastatic Her-2-negative breast cancer
por: Abdel Kader Y, et al.
Publicado: (2013)

Effect of Fuzheng Qingdu Therapy for Metastatic Gastric Cancer is Associated With Improved Survival: A Multicenter Propensity-Matched Study
por: Chao Hou MD, et al.
Publicado: (2021)

The incidence rate of female breast cancer in Saudi Arabia: an observational descriptive epidemiological analysis of data from Saudi Cancer Registry 2001–2008
por: Alghamdi IG, et al.
Publicado: (2013)

Cellphone enabled point-of-care assessment of breast tumor cytology and molecular HER2 expression from fine-needle aspirates
por: Daniel Y. Joh, et al.
Publicado: (2021)

Barrier protective use of skin care to prevent chemotherapy-induced cutaneous symptoms and to maintain quality of life in patients with breast cancer
por: Wohlrab J, et al.
Publicado: (2014)

A common goal to CARE: Cancer Advocates, Researchers, and Clinicians Explore current treatments and clinical trials for breast cancer brain metastases
por: Natalie S. Joe, et al.
Publicado: (2021)

Lapatinib in patients with metastatic breast cancer following initial treatment with trastuzumab: an economic analysis from the Brazilian public health care perspective
por: Machado M, et al.
Publicado: (2012)

Author Correction: Cellphone enabled point-of-care assessment of breast tumor cytology and molecular HER2 expression from fine-needle aspirates
por: Daniel Y. Joh, et al.
Publicado: (2021)

Inherited predisposition to breast cancer in the Carolina Breast Cancer Study
por: Tom Walsh, et al.
Publicado: (2021)

Identification of genes involved in breast cancer and breast cancer stem cells
por: Apostolou P, et al.
Publicado: (2015)

Decrease in early mortality for newly diagnosed multiple myeloma patients in the Netherlands: a population-based study
por: Mirian Brink, et al.
Publicado: (2021)

Correlation Between Average Segment Width and Gamma Passing Rate as a Function of MLC Position Error in Volumetric Modulated Arc Therapy
por: Young Min Moon PhD, et al.
Publicado: (2021)

Dormancy in breast cancer
por: Banys M, et al.
Publicado: (2012)

Can population breast screening programs be leveraged to reduce the burden of breast cancer?
por: Nehmat Houssami
Publicado: (2021)

Dynamic contrast-enhanced breast MRI features correlate with invasive breast cancer angiogenesis
por: Jennifer Xiao, et al.
Publicado: (2021)

The contribution of pathogenic variants in breast cancer susceptibility genes to familial breast cancer risk
por: Thomas P. Slavin, et al.
Publicado: (2017)

Bones, breasts, and bisphosphonates: rationale for the use of zoledronic acid in advanced and early breast cancer
por: Allan Lipton
Publicado: (2011)

Cardiac Dose Control and Optimization Strategy for Left Breast Cancer Radiotherapy With Non-Uniform VMAT Technology
por: Jianjian Qiu PhD, et al.
Publicado: (2021)

TACE Combined with HIFU Versus Surgical Resection for Single Hepatocellular Carcinoma with Child-Pugh B Cirrhosis in Overall Survival and Progression-Free Survival: A Retrospective Study
por: Qiwei Zhang MM, et al.
Publicado: (2021)

Circulating tumor cell number and endocrine therapy index in ER positive metastatic breast cancer patients
por: Costanza Paoletti, et al.
Publicado: (2021)

Tumor-associated autoantibodies from mouse breast cancer models are found in serum of breast cancer patients
por: Sasha E. Stanton, et al.
Publicado: (2021)

Breast adipocyte size associates with ipsilateral invasive breast cancer risk after ductal carcinoma in situ
por: Mathilde M. M. Almekinders, et al.
Publicado: (2021)

The impact of mammographic screening on the subsequent breast cancer risk associated with biopsy-proven benign breast disease
por: Francisco Beca, et al.
Publicado: (2021)

An alternative model for (breast) cancer predisposition
por: Erik Teugels, et al.
Publicado: (2017)